Clinical Trials Directory

Trials / Unknown

UnknownNCT03173352

A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China

Status
Unknown
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Zhujiang Hospital · Academic / Other
Sex
All
Age
12 Months
Healthy volunteers
Accepted

Summary

Infant hemangioma(IH) is the most common benign vascular tumor of infancy with the estimated incidence varies 1% to 12%.However, in China, the incidence of infant hemangioma and related epidemiological data remains unclear. So, the investigators designed the study for the following purposes: 1, to aware the incidence of infantile hemangioma and understand the related risk factorsin China; 2, to understand the clinical characteristics of infantile hemangioma and the risk factors for complications; 3, to investigate the level of knowledge, treatment options in infant hemangioma in Chinese doctors; 3, to improve the awareness of infantile hemangioma in parents and provide more advice for pregnancy counseling and eugenics.

Conditions

Timeline

Start date
2015-12-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2017-06-01
Last updated
2017-06-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03173352. Inclusion in this directory is not an endorsement.